Flavia Raggi

Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments

Andrea Visentin, Monica Facco, Carmela Gurrieri et al. · Clinical Lymphoma Myeloma & Leukemia · 2019 · 45 citations

Medicine, Hematology, Oncology +8

HSP70/HSF1 axis, regulated <i>via</i> a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia

Federica Frezzato, Flavia Raggi, Veronica Martini et al. · International Journal of Cancer · 2019 · 40 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients

Andrea Visentin, Silvia Imbergamo, Carmela Gurrieri et al. · European Journal of Cancer · 2016 · 35 citations

Medicine, Immunology, Oncology +16

Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells

Veronica Martini, Cristina Gattazzo, Federica Frezzato et al. · British Journal of Haematology · 2017 · 29 citations · Full text

Medicine, Cell Biology, Molecular Biology +16

The <i>epg5</i> knockout zebrafish line: a model to study Vici syndrome

Giacomo Meneghetti, Tatjana Skobo, Martina Chrisam et al. · Autophagy · 2019 · 27 citations · Full text

Life Sciences, Biology, Genetics +17